Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553275 · ClinicalTrials.gov registry record · NA
Permissive Intrapartum Glucose Control
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT05553275 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 96 participants.
The verdict
NCT05553275, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.
Interventions
- PROCEDURE Usual Care
- PROCEDURE Permissive intrapartum glucose control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2023-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05553275
The ClinicalTrials.gov registry entry for NCT05553275 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05553275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05553275 about?
NCT05553275 is a clinical study titled "Permissive Intrapartum Glucose Control". The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.
What is the current status of trial NCT05553275?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2022-10-05. Estimated completion is 2023-08-13.
What interventions are being tested in trial NCT05553275?
The interventions under investigation include: Usual Care (PROCEDURE), Permissive intrapartum glucose control (PROCEDURE).
Who is sponsoring clinical trial NCT05553275?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.